Dare Bioscience, Inc. Operating Lease Cost
Dare Bioscience, Inc. (DARE) reported Operating Lease Cost of $191.35 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- Dare Bioscience, Inc. operating lease, cost for the quarter ending 2026-06-30 was $191.35K, a 14.90% decline year-over-year.
- Dare Bioscience, Inc. operating lease, cost for the quarter ending 2026-03-31 was $196.31K, a 0.31% decline year-over-year.
- Dare Bioscience, Inc. operating lease, cost for the quarter ending 2025-12-31 was $202.04K, a 11.46% increase year-over-year.
- Dare Bioscience, Inc. operating lease, cost for the quarter ending 2025-09-30 was $202.00K, a 4.12% increase year-over-year.
- Dare Bioscience, Inc. operating lease, cost for fiscal 2025 was $828.04K, a 8.06% increase from fiscal 2024.
- Dare Bioscience, Inc. operating lease, cost for fiscal 2024 was $766.26K, a 27.71% increase from fiscal 2023.
- Dare Bioscience, Inc. operating lease, cost for fiscal 2023 was $600.00K, a 0.00% change from fiscal 2022.
- Dare Bioscience, Inc. operating lease, cost for fiscal 2022 was $600.00K, a 6.95% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $191.35K 10-Q · filed 2026-08-13 | $387.66K 10-Q · filed 2026-08-13 | $589.70K derived: sum of 3 quarters · filed 2026-08-13 | $791.70K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $196.31K 10-Q · filed 2026-05-14 | $398.34K derived: sum of 2 quarters · filed 2026-05-14 | $600.34K derived: sum of 3 quarters · filed 2026-05-14 | $825.19K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $202.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $404.04K derived: sum of 2 quarters · filed 2026-03-26 | $628.88K derived: sum of 3 quarters · filed 2026-08-13 | $828.04K 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $202.00K 10-Q · filed 2025-11-13 | $426.85K derived: sum of 2 quarters · filed 2026-08-13 | $626.00K 10-Q · filed 2025-11-13 | $805.02K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $224.85K 10-Q · filed 2026-08-13 | $225.00K 10-Q · filed 2025-08-14 | $424.01K 10-Q · filed 2026-08-13 | $424.00K 10-Q · filed 2025-08-14 | $603.02K derived: sum of 3 quarters · filed 2026-08-13 | $797.02K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $196.92K 10-Q · filed 2026-05-14 | $197.00K 10-Q · filed 2025-05-13 | $378.18K derived: sum of 2 quarters · filed 2026-05-14 | $572.17K derived: sum of 3 quarters · filed 2026-05-14 | $763.17K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $181.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $375.26K derived: sum of 2 quarters · filed 2026-03-26 | $566.26K derived: sum of 3 quarters · filed 2026-03-26 | $766.26K 10-K · filed 2026-03-26 | $800.00K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $194.00K 10-Q · filed 2025-11-13 | $385.00K derived: sum of 2 quarters · filed 2025-11-13 | $585.00K 10-Q · filed 2025-11-13 | $776.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $191.00K 10-Q · filed 2025-08-14 | $391.00K 10-Q · filed 2025-08-14 | $582.00K derived: sum of 3 quarters · filed 2025-08-14 | $707.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-13 | $391.00K derived: sum of 2 quarters · filed 2025-05-13 | $516.00K derived: sum of 3 quarters · filed 2025-05-13 | $661.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $316.00K derived: sum of 2 quarters · filed 2025-03-31 | $461.00K derived: sum of 3 quarters · filed 2025-03-31 | $600.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $125.00K 10-Q · filed 2024-11-14 | $270.00K derived: sum of 2 quarters · filed 2024-11-14 | $409.00K 10-Q · filed 2024-11-14 | $540.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $145.00K 10-Q · filed 2024-08-12 | $284.00K 10-Q · filed 2024-08-12 | $415.00K derived: sum of 3 quarters · filed 2024-08-12 | $531.00K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $139.00K 10-Q · filed 2024-05-14 | $270.00K derived: sum of 2 quarters · filed 2024-05-14 | $386.00K derived: sum of 3 quarters · filed 2024-05-14 | $536.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $247.00K derived: sum of 2 quarters · filed 2024-03-28 | $397.00K derived: sum of 3 quarters · filed 2024-03-28 | $600.00K 10-K · filed 2024-03-28 | $602.00K 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $116.00K 10-Q · filed 2023-11-09 | $266.00K derived: sum of 2 quarters · filed 2023-11-09 | $469.00K 10-Q · filed 2023-11-09 | $576.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $150.00K 10-Q · filed 2023-08-10 | $340.00K 10-Q · filed 2023-08-10 | $460.00K derived: sum of 3 quarters · filed 2023-08-10 | $594.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $169.00K 10-Q · filed 2023-05-11 | $310.00K derived: sum of 2 quarters · filed 2023-05-11 | $444.00K derived: sum of 3 quarters · filed 2023-05-11 | $595.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $275.00K derived: sum of 2 quarters · filed 2023-03-30 | $426.00K derived: sum of 3 quarters · filed 2023-03-30 | $561.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $134.00K 10-Q · filed 2022-11-10 | $285.00K derived: sum of 2 quarters · filed 2022-11-10 | $420.00K 10-Q · filed 2022-11-10 | $627.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $151.00K 10-Q · filed 2022-08-09 | $286.00K 10-Q · filed 2022-08-09 | $493.00K derived: sum of 3 quarters · filed 2022-08-09 | $569.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $135.00K 10-Q · filed 2022-05-12 | $342.00K derived: sum of 2 quarters · filed 2022-05-12 | $418.00K derived: sum of 3 quarters · filed 2022-05-12 | $494.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $283.00K derived: sum of 2 quarters · filed 2022-03-31 | $359.00K derived: sum of 3 quarters · filed 2022-03-31 | $435.00K 10-K · filed 2022-03-31 | $303.80K 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $76.00K 10-Q · filed 2021-11-10 | $152.00K derived: sum of 2 quarters · filed 2021-11-10 | $228.00K 10-Q · filed 2021-11-10 | $393.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $76.00K 10-Q · filed 2021-08-12 | $152.00K 10-Q · filed 2021-08-12 | $317.00K derived: sum of 3 quarters · filed 2021-08-12 | $344.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $99.00K 10-Q · filed 2021-05-13 | $76.00K 10-Q · filed 2020-05-14 | $241.00K derived: sum of 2 quarters · filed 2021-05-13 | $268.00K derived: sum of 3 quarters · filed 2021-05-13 | $295.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $169.00K derived: sum of 2 quarters · filed 2021-03-30 | $196.00K derived: sum of 3 quarters · filed 2021-03-30 | $223.00K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $27.00K 10-Q · filed 2020-11-12 | $27.04K 10-Q · filed 2019-11-12 | $54.00K derived: sum of 2 quarters · filed 2020-11-12 | $81.00K 10-Q · filed 2020-11-12 | $81.11K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $27.00K 10-Q · filed 2020-08-12 | $27.04K 10-Q · filed 2019-08-14 | $54.00K 10-Q · filed 2020-08-12 | $54.08K 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $27.00K 10-Q · filed 2020-05-14 | $27.04K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |